Respiratory co-and superinfections in COVID-19

There are few publications on the impact of coinfection and superinfection in patients with COVID-19. Patients with higher severity are much more prone to secondary bacterial, fungal or viral infections. The overuse of antimicrobials in many viral infections (including SARS-CoV-2 infections) undoubt...

Full description

Saved in:

Bibliographic Details
Published in:	Revista española de quimioterapia Vol. 34 Suppl 1; no. Suppl 1; pp. 69 - 71
Main Author:	Del Pozo, J L
Format:	Journal Article
Language:	English
Published:	Spain Sociedad Española de Quimioterapia 01-09-2021
Subjects:	Coinfection COVID-19 Humans SARS-CoV-2 Superinfection Update on the management of SARS-CoV-2 infection Virus Diseases - complications
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	There are few publications on the impact of coinfection and superinfection in patients with COVID-19. Patients with higher severity are much more prone to secondary bacterial, fungal or viral infections. The overuse of antimicrobials in many viral infections (including SARS-CoV-2 infections) undoubtedly contributes to the current antimicrobial resistance crisis. In the context of COVID-19, we are witnessing an increase in multidrug-resistant bacterial infections in our hospitals. The heterogeneity of published studies makes it critical to perform more large-scale studies to better understand the pathogenesis of coinfections or superinfections in the COVID-19 patient.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	0214-3429 1988-9518
DOI:	10.37201/req/s01.20.2021